全文获取类型
收费全文 | 17195篇 |
免费 | 984篇 |
国内免费 | 780篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 158篇 |
妇产科学 | 91篇 |
基础医学 | 2048篇 |
口腔科学 | 970篇 |
临床医学 | 1149篇 |
内科学 | 3019篇 |
皮肤病学 | 186篇 |
神经病学 | 2122篇 |
特种医学 | 318篇 |
外国民族医学 | 3篇 |
外科学 | 1461篇 |
综合类 | 2167篇 |
现状与发展 | 2篇 |
预防医学 | 985篇 |
眼科学 | 176篇 |
药学 | 3233篇 |
6篇 | |
中国医学 | 551篇 |
肿瘤学 | 261篇 |
出版年
2023年 | 166篇 |
2022年 | 396篇 |
2021年 | 572篇 |
2020年 | 345篇 |
2019年 | 336篇 |
2018年 | 357篇 |
2017年 | 377篇 |
2016年 | 368篇 |
2015年 | 481篇 |
2014年 | 817篇 |
2013年 | 1163篇 |
2012年 | 767篇 |
2011年 | 791篇 |
2010年 | 764篇 |
2009年 | 742篇 |
2008年 | 753篇 |
2007年 | 712篇 |
2006年 | 750篇 |
2005年 | 694篇 |
2004年 | 601篇 |
2003年 | 585篇 |
2002年 | 552篇 |
2001年 | 502篇 |
2000年 | 468篇 |
1999年 | 426篇 |
1998年 | 437篇 |
1997年 | 461篇 |
1996年 | 405篇 |
1995年 | 344篇 |
1994年 | 306篇 |
1993年 | 235篇 |
1992年 | 249篇 |
1991年 | 232篇 |
1990年 | 186篇 |
1989年 | 218篇 |
1988年 | 170篇 |
1987年 | 138篇 |
1986年 | 131篇 |
1985年 | 192篇 |
1984年 | 136篇 |
1983年 | 114篇 |
1982年 | 101篇 |
1981年 | 105篇 |
1980年 | 68篇 |
1979年 | 63篇 |
1978年 | 47篇 |
1977年 | 32篇 |
1976年 | 27篇 |
1975年 | 19篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
目的:对应用低分子肝素钙与奥扎格雷联合对患有脑血栓疾病的患者实施治疗的临床效果进行研究。方法整群选择在该院2012年12月—2014年12月就诊的患有脑血栓疾病的患者86例,随机分为对照组和治疗组,每组43例。采用奥扎格雷对对照组患者实施治疗;采用低分子肝素钙与奥扎格雷联合对治疗组患者实施治疗。对比神经功能缺损评分在药物治疗前后的变化幅度、脑神经功能恢复正常时间和脑血栓药物治疗计划实施总时间、脑血栓疾病药物治疗效果、用药期间的不良反应人数。结果治疗组患者神经功能缺损评分在药物治疗前后的变化幅度明显大于对照组;脑神经功能恢复正常时间(9.66±2.41)d和脑血栓药物治疗计划实施总时间(13.28±2.14)d明显短于对照组(13.62±3.47)、(17.39±3.20)d;脑血栓疾病药物治疗效果(总有效率90.6%)明显优于对照组(总有效率69.8%);用药期间的不良反应人数(1例)明显少于对照组(8例)。结论应用低分子肝素钙与奥扎格雷联合对患有脑血栓疾病的患者实施治疗的临床效果非常明显。 相似文献
2.
I. R. Reid 《Journal of internal medicine》2015,277(6):690-706
There is an increasing number of effective therapies for fracture prevention in adults at risk of osteoporosis. However, shortcomings in the evidence underpinning our management of osteoporosis still exist. Evidence of antifracture efficacy in the groups of patients who most commonly use calcium and vitamin D supplements is lacking, the safety of calcium supplements is in doubt, and the safety and efficacy of high doses of vitamin D give cause for concern. Alendronate, risedronate, zoledronate and denosumab have been shown to prevent spine, nonspine and hip fractures; in addition, teriparatide and strontium ranelate prevent both spine and nonspine fractures, and raloxifene and ibandronate prevent spine fractures. However, most trials provide little information regarding long‐term efficacy or safety. A particular concern at present is the possibility that oral bisphosphonates might cause atypical femoral fractures. Observational data suggest that the incidence of this type of fracture increases steeply with duration of bisphosphonate use, resulting in concern that the benefit–risk balance may become negative in the long term, particularly in patients in whom the osteoporotic fracture risk is not high. Therefore, reappraisal of ongoing use of bisphosphonates after about 5 years is endorsed by expert consensus, and ‘drug holidays’ should be considered at this time. Further studies are needed to guide clinical practice in this area. 相似文献
3.
4.
《Vaccine》2020,38(39):6141-6152
Influenza vaccination is considered the most valuable means to prevent and control seasonal influenza infections, which causes various clinical symptoms, ranging from mild cough and fever to even death. Among various influenza vaccine types, the inactivated subunit type is known to provide improved safety with reduced reactogenicity. However, there are some drawbacks associated with inactivated subunit type vaccines, with the main ones being its low immunogenicity and the induction of Th2-biased immune responses. In this study, we investigated the role of a single-stranded RNA (ssRNA) derived from the intergenic region in the internal ribosome entry site of the Cricket paralysis virus as an adjuvant rather than the universal vaccine for a seasonal inactivated subunit influenza vaccine. The ssRNA adjuvant stimulated not only well-balanced cellular (indicated by IgG2a, IFN-γ, IL-2, and TNF-α) and humoral (indicated by IgG1 and IL-4) immune responses but also a mucosal immune response (indicated by IgA), a key protector against respiratory virus infections. It also increases the HI titer, the surrogate marker of influenza vaccine efficacy. Furthermore, ssRNA adjuvant confers cross-protective immune responses against heterologous influenza virus infection while promoting enhanced viral clearance. Moreover, ssRNA adjuvant increases the number of memory CD4+ and CD8+ T cells, which can be expected to induce long-term immune responses. Therefore, this ssRNA-adjuvanted seasonal inactivated subunit influenza vaccine might be the best influenza vaccine generating robust humoral and cellular immune responses and conferring cross-protective and long-term immunity. 相似文献
5.
Bi-Hua BIE Yong CHEN Zhi-Qi ZHAO Institute of Neurobiology Fu-Dan University Shanghai China Institute of Shanghai Physiology Chinese Academy of Sciences Shanghai China 《中国神经科学杂志》2006,(2)
Objective Ligustrazine, also named as tetramethylpyrazine, is a compound purified from Ligusticum chuanxiong hort and has ever been testified to be a calcium antagonist. The present investigation was to determine the antinoci-ceptive effect of ligustrazine and, if any, the peripheral ionic mechanism involved. Methods Paw withdrawal Latency ( PWL) to noxious heating was measured in vivo and whole-cell patch recording was performed on small dorsal root ganglion (DRG) neurons. Results Intraplantar injection of ligustrazine (0.5 mg in 25μl) significantly prolonged the withdrawal latency of ipsilateral hindpaw to noxious heating in the rat. Ligustrazine not only reversibly inhibited high-voltage gated calcium current of dorsal root ganglion (DRG) neuron in dose-dependent manner with IC50 of 1.89 mmol/L, but also decreased tetrodotoxin (TTX) -resistant sodium current in relatively selective and dose-dependent manner with IC50 of 2.49 mmol/L. Conclusion The results suggested that ligustrazine could elevate the threshold of thermal nociception through inhibiting the high-voltage gated calcium current and TTX-resistant sodium current of DRG neuron in the rat. 相似文献
6.
缺氧缺血性脑病新生鼠补钙前后脑细胞,红细胞内外钙的变化 总被引:31,自引:0,他引:31
为了观察一般剂量补钙对缺氧缺血性脑病(HIE)脑细胞和红细胞内外钙变化的影响,以探讨HIE时补钙是否增加脑细胞钙超载,用HIE新生动物模型进行了实验研究,结果表明:(1)缺氧缺血时红细胞、脑细胞及脑组织出现钙积聚;(2)补钙后,血浆总钙浓度明显升高,而脑细胞、脑组织及红细胞钙积聚并未加重;(3)血浆总钙浓度与脑细胞或红细胞胞浆游离钙离子浓度无相关关系。提示:(1)HIE时钙内流可能是全身性的;(2)对HIE并低钙血症患儿吸氧后一般剂量补钙可能是安全的。 相似文献
7.
提要本研究是在大鼠VD_3+Nicotine引起的心血管钙超载模型上观察心钠素(ANF)治疗(10ug ·kg~-1/d),对钙超载的影响。结果发现,钙超载组动物主动脉、心肌组织钙含量较对照组分别增高24倍(54.4±2.2vs 2.3±0.04fumol/gww)和9倍(16.9±2.1vs1.8±0.1umol/gww)。ANF治疗能显著抑制钙超载的发生,主动脉和心肌组织钙含量较钙超载组分别降低92%(3.8±0.4 umol/gww)和66%(5.6±0.6umol/gww)。离体滋流的钙超载血管环较对照组对去甲肾上腺素收缩反应增强;对乙酰胆碱舒张反应减弱,对硝普钠舒张反应无影响。ANF能显著改善钙超载所致的血管反应性障碍。实验结果表明,ANF具有显著的防治心血管钙超载的作用。 相似文献
8.
AClinicalStudyofReversingLeftVentricularHypertrophyinHypertensivePatientsbyAdalatZhangFumin(张馥敏)XuDi(许迪)YongYonghong(雍永宏)Chen... 相似文献
9.
R GOKAL 《Nephrology (Carlton, Vic.)》1996,2(S1):s159-s162
Summary: Current peritoneal dialysis solutions are not biocompatible, particularly in respect to low pH, high osmolality and use of lactate. In addition, glucose is not an ideal osmotic agent. Recent advances in the formulation of peritoneal dialysis fluids aim to provide a more physiological environment to preserve membrane integrity. the effects of pH and lactate have been overcome by the use of bicarbonate based solutions whilst icodextrin (glucose polymers) often prolonged ultrafiltration in spite of being isomotic to uraemic plasma. Future formulations will see a combination of osmotic agents (including amino acids) and bicarbonate to achieve a more biocompatible solution whilst still meeting the ultrafiltration needs of the patients. Additives (glycosaminoglycans, procysteine) may protect the peritoneum from free radical injury. 相似文献
10.